Domov › Skvamóznocelulárny karcinóm hlavy a krku › Virginia › Arlington
Klinické štúdie Skvamóznocelulárny karcinóm hlavy a krku v meste Arlington, VA
26 štúdií pre Skvamóznocelulárny karcinóm hlavy a krku hľadá účastníkov v zariadeniach v meste Arlington a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
Prebieha náborFáza 1
- Site 04, Fairfax · 11 míľ odtiaľ
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
Prebieha náborFáza 1
- ALX Center 2, Fairfax · 11 míľ odtiaľ
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
Prebieha náborFáza 3
- Virginia Cancer Specialists, Fairfax · 11 míľ odtiaľ
A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer
Prebieha náborFáza 1/2
- Virginia Cancer Specialists, Fairfax · 11 míľ odtiaľ
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
Prebieha náborFáza 2
- Inova Fairfax Hospital, Falls Church · 4 míľ odtiaľ
- Inova Schar Cancer Institute, Fairfax · 11 míľ odtiaľ
- Inova Fair Oaks Hospital, Fairfax · 11 míľ odtiaľ
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Prebieha náborFáza 1
- Virginia Cancer Specialists, Fairfax · 11 míľ odtiaľ
A Study of ASP388B Given by Itself and With Standard Therapies in Participants With Solid Tumors
Prebieha náborFáza 1/2
- NEXT Virginia, Fairfax · 11 míľ odtiaľ
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
Prebieha náborFáza 1/2
- NEXT Oncology, Fairfax · 11 míľ odtiaľ
A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Prebieha náborFáza 2
- Inova Schar Cancer Institute, Fairfax · 11 míľ odtiaľ
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
Prebieha náborFáza 1/2
- Research Site, Fairfax · 11 míľ odtiaľ
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
Prebieha náborFáza 1
- Normunity Investigational Site, Fairfax · 11 míľ odtiaľ
A Study of DM005 in Patients With Advanced Solid Tumors
Prebieha náborFáza 1/2
- NEXT Oncology Virginia, Fairfax · 11 míľ odtiaľ
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Prebieha náborFáza 1/2
- Virginia Cancer Specialists, Fairfax · 11 míľ odtiaľ
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
Prebieha náborFáza 1
- NEXT Virginia, Fairfax · 11 míľ odtiaľ
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Prebieha náborFáza 1/2
- USO-Virginia Cancer Specialists, PC, Fairfax · 11 míľ odtiaľ
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Prebieha náborFáza 1
- Virginia Cancer Specialists, Fairfax · 11 míľ odtiaľ
A Study to Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid Tumors
Prebieha náborFáza 1/2
- NEXT Oncology Virginia, Fairfax · 11 míľ odtiaľ
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Prebieha náborFáza 1/2
- NEXT, Fairfax · 11 míľ odtiaľ
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
Prebieha náborFáza 1
- Virginia Cancer Specialists - Fairfax /ID# 232592, Fairfax · 11 míľ odtiaľ
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
Prebieha náborFáza 1
- NEXT Texas LLC - Virginia, Fairfax · 11 míľ odtiaľ
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
Prebieha náborFáza 1/2
- NEXT Virginia, Fairfax · 11 míľ odtiaľ
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Prebieha náborFáza 1/2
- NEXT Virginia, Fairfax · 11 míľ odtiaľ
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
Prebieha náborFáza 1
- Dren Investigational Site, Fairfax · 11 míľ odtiaľ
Study to Evaluate LB-LR1109, Administered Alone for the Treatment of Solid Tumor and in Combination With Atezolizumab for the Treatment of NSCLC
Prebieha náborFáza 1
- NEXT Oncology, Fairfax · 11 míľ odtiaľ
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Prebieha náborFáza 1/2
- Research Site 102, Fairfax · 11 míľ odtiaľ
- Research Site 112, Fairfax · 11 míľ odtiaľ
A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors
Prebieha náborFáza 1/2
- Virginia Cancer Specialists, Fairfax · 11 míľ odtiaľ
Štúdie Skvamóznocelulárny karcinóm hlavy a krku v iných mestách
- Houston, TX47 štúdií
- Los Angeles, CA42 štúdií
- Boston, MA40 štúdií
- New York City, NY39 štúdií
- Nashville, TN39 štúdií
- St. Louis, MO28 štúdií
- Philadelphia, PA26 štúdií
- Chicago, IL26 štúdií
- Atlanta, GA24 štúdií
- San Antonio, TX22 štúdií
- New Haven, CT22 štúdií
- Pittsburgh, PA22 štúdií
Iné štúdie v Arlington
- Nemalobunkový karcinóm pľúc104 štúdií
- Metastatická rakovina53 štúdií
- Kolorektálny karcinóm52 štúdií
- Rakovina (všetky typy)48 štúdií
- Rakovina prsníka47 štúdií
- Rakovina vaječníkov46 štúdií
- Rakovina pľúc41 štúdií
- Rakovina endometria39 štúdií
- Rakovina pankreasu33 štúdií
- Malobuněčný rakovina plic23 štúdií
- Rakovina žalúdka20 štúdií
- Trojnásobne negatívny karcinóm prsníka20 štúdií
Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.